Literature DB >> 27053336

Piperlongumine inhibits gastric cancer cells via suppression of the JAK1,2/STAT3 signaling pathway.

Baoji Song1, Hongjie Zhan2, Quan Bian1, Junping Gu1.   

Abstract

Piperlongumine (PL), a major active component of long peppers, has been reported to possess anti‑cancer properties; however, its effect on gastric cancer (GC) has remained to be demonstrated. The present study assessed the effects of PL on the MKN45 and AGS GC cell lines and explored the underlying mechanisms. An MTT assay revealed that PL suppressed the proliferation of GC cells, while flow cytometric analysis showed that PL inhibited cell cycle progression. Furthermore, Transwell assays revealed the inhibitory effects of PL on the invasion and migration of GC cells. In addition, PL reduced the phosphorylation of Janus kinase (JAK)1, JAK2 and signal transducer and activator of transcription (STAT)3 in a concentration‑dependent manner, as indicated by western blot analysis, and decreased the expression of STAT3‑dependent tumor‑associated genes in GC cells, as revealed by PCR analysis. In conclusion, the present study was the first, to the best of our knowledge, to reveal the efficacy of PL against GC. The consumption of long peppers is therefore recommended for the prevention and treatment of GC, and PL may be a promising candidate drug for treating GC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27053336     DOI: 10.3892/mmr.2016.5091

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer.

Authors:  Sandeep Kumar; Navneet Agnihotri
Journal:  Mol Cell Biochem       Date:  2021-01-12       Impact factor: 3.396

Review 2.  Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.

Authors:  Elham Patrad; Solmaz Khalighfard; Taghi Amiriani; Vahid Khori; Ali Mohammad Alizadeh
Journal:  Cell Oncol (Dordr)       Date:  2022-09-23       Impact factor: 7.051

3.  Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation.

Authors:  Christopher J Hall; Leslie E Sanderson; Lisa M Lawrence; Bregina Pool; Maarten van der Kroef; Elina Ashimbayeva; Denver Britto; Jacquie L Harper; Graham J Lieschke; Jonathan W Astin; Kathryn E Crosier; Nicola Dalbeth; Philip S Crosier
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 14.808

4.  Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway.

Authors:  Di Chen; Xinyue Wei; Ke Yang; Xinyue Liu; Yujin Song; Futing Bai; Yi Jiang; Yuhang Guo; Rajiv Kumar Jha
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

5.  Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.

Authors:  Cinara O D'Sousa Costa; João H Araujo Neto; Ingrid R S Baliza; Rosane B Dias; Ludmila de F Valverde; Manuela T A Vidal; Caroline B S Sales; Clarissa A G Rocha; Diogo R M Moreira; Milena B P Soares; Alzir A Batista; Daniel P Bezerra
Journal:  Oncotarget       Date:  2017-11-01

6.  The effect of piperlongumine on endothelial and lung adenocarcinoma cells with regulated expression of profilin-1.

Authors:  Maciej Gagat; Marta Hałas-Wiśniewska; Wioletta Zielińska; Magdalena Izdebska; Dariusz Grzanka; Alina Grzanka
Journal:  Onco Targets Ther       Date:  2018-11-22       Impact factor: 4.147

Review 7.  The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer-A Review on In Vitro, In Vivo, and Clinical Studies.

Authors:  Sylwia Nakonieczna; Aneta Grabarska; Wirginia Kukula-Koch
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

8.  miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.

Authors:  Xiuting Hu; Yanbo Wang; Hongwei Liang; Qian Fan; Ruichi Zhu; Jiayi Cui; Weijie Zhang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Zhen Zhou; Xi Chen
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

Review 9.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

10.  Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma.

Authors:  Flávio Rogério da Nóbrega; Ozlem Ozdemir; Sheila Cristina S Nascimento Sousa; Joice Nascimento Barboza; Hasan Turkez; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2018-06-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.